Found 15 matching trials
Comparison of the Efficacy and Safety of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Insufficiently Controlled With Non-insulin Antidiabetic Therapy PHASE3 Primary Objective:
To compare the efficacy of insulin glargine (U300) and ...
Show More Location
Investigational Site Number 1560039
Learn More & Join Trial
Euglycemic Clamp Study Comparing Two New Insulin Glargine Formulations in Subjects With Type 1 Diabetes Mellitus PHASE1 Primary Objective:
To demonstrate equivalence in exposure to insulin glarg...
Show More Location
Investigational Site Number 276001
Learn More & Join Trial
Single Dose Study With a New Insulin Glargine Formulation and Lantus® in Japanese Patients With Type 1 Diabetes Mellitus PHASE1 Primary Objective:
To compare the pharmacodynamic properties of two differ...
Show More Location
Investigational Site Number 392001
Learn More & Join Trial
Repeated Dosing Study With a New Insulin Glargine Formulation and Lantus® in Patients With Type 1 Diabetes Mellitus PHASE1 Primary Objective:
To assess the safety and tolerability of two dose level...
Show More Location
Investigational site number 276001
Learn More & Join Trial
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin PHASE3 Primary Objective:
* To compare the efficacy of insulin glargine new formu...
Show More Location
Investigational Site Number 840156
Learn More & Join Trial
Ease of Use and Safety of the New U300 Pen Injector in Insulin-Naïve Patients With T2DM PHASE3 Primary Objective:
To demonstrate the ease of use of the U300 pen injector...
Show More Location
Investigational Site Number 276011
Learn More & Join Trial
Comparison of a New Formulation of Insulin Glargine With Lantus® in Japanese Patients With Type 1 Diabetes Mellitus PHASE3 Primary Objective:
To compare the efficacy of a new formulation of insulin...
Show More Location
Investigational Site Number 392119
Learn More & Join Trial
Comparison of a New Formulation of Insulin Glargine With Lantus® Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes Mellitus PHASE3 Primary Objective:
To compare the efficacy of a new formulation of insulin...
Show More Location
Investigational Site Number 392226
Learn More & Join Trial
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus on Basal Plus Mealtime Insulin PHASE2 Primary Objective:
* To compare the glucose control during treatment with ...
Show More Location
Investigational Site Number 840002
Learn More & Join Trial
Repeated Dose Study With a New Insulin Glargine Formulation and Lantus® on 24-hour Glucose Profile in Japanese Patients With Type 1 Diabetes Mellitus PHASE1 Primary Objective:
\- To compare the 24-hour glycemic profile in continuou...
Show More Location
Investigational Site Number 392001
Learn More & Join Trial